New York State Teachers Retirement System Sells 12,630 Shares of Avanos Medical, Inc. (NYSE:AVNS)

New York State Teachers Retirement System reduced its position in Avanos Medical, Inc. (NYSE:AVNS) by 16.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 62,585 shares of the company’s stock after selling 12,630 shares during the quarter. New York State Teachers Retirement System owned approximately 0.14% of Avanos Medical worth $897,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also modified their holdings of the company. Comerica Bank boosted its position in shares of Avanos Medical by 3.4% in the fourth quarter. Comerica Bank now owns 22,903 shares of the company’s stock worth $365,000 after purchasing an additional 755 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Avanos Medical by 3.6% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,834 shares of the company’s stock worth $411,000 after purchasing an additional 901 shares during the period. EP Wealth Advisors LLC boosted its position in shares of Avanos Medical by 14.6% in the fourth quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company’s stock worth $161,000 after purchasing an additional 1,289 shares during the period. Azzad Asset Management Inc. ADV boosted its position in shares of Avanos Medical by 3.5% in the first quarter. Azzad Asset Management Inc. ADV now owns 41,039 shares of the company’s stock worth $588,000 after purchasing an additional 1,404 shares during the period. Finally, Gotham Asset Management LLC boosted its position in shares of Avanos Medical by 5.3% in the fourth quarter. Gotham Asset Management LLC now owns 28,234 shares of the company’s stock worth $449,000 after purchasing an additional 1,425 shares during the period. 95.17% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised shares of Avanos Medical from a “hold” rating to a “buy” rating in a report on Wednesday, March 19th.

Avanos Medical Price Performance

AVNS stock opened at $12.27 on Thursday. Avanos Medical, Inc. has a one year low of $11.68 and a one year high of $25.36. The company’s fifty day moving average price is $12.43 and its 200-day moving average price is $14.07. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.56 and a current ratio of 2.57. The company has a market capitalization of $567.36 million, a PE ratio of -1.47 and a beta of 1.12.

Avanos Medical (NYSE:AVNS) last released its earnings results on Tuesday, May 6th. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.19 by $0.07. Avanos Medical had a negative net margin of 55.80% and a positive return on equity of 6.26%. The firm had revenue of $167.50 million for the quarter, compared to the consensus estimate of $161.75 million. During the same quarter in the previous year, the firm earned $0.22 earnings per share. The company’s quarterly revenue was up .8% compared to the same quarter last year. On average, equities analysts anticipate that Avanos Medical, Inc. will post 1.32 EPS for the current fiscal year.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.